Drug intelligence / Profile preview

Zaoshen Anshen Oral Liquid

Development stage: Unknown
Lead developer: Yiling Pharmaceutical
Administration: Oral

Overview

Zaoshen Anshen Oral Liquid is a patented Traditional Chinese Medicine (TCM) developed by Shijiazhuang Yiling Pharmaceutical for the treatment of insomnia and sleep-related disorders. The formulation is based on TCM principles of nourishing the heart and kidney to calm the spirit (Anshen). It is primarily composed of botanical extracts, including Ziziphus jujuba (Jujube) and Morus alba (Mulberry fruit). The product is approved in China and is indicated for patients experiencing poor sleep quality, difficulty falling asleep, and symptoms associated with heart-kidney deficiency and neurasthenia.

Brand names: Zaoshen Anshen Oral Liquid
Other names: Zaoshen Anshen Koufuye

Beyond the preview

Go deeper on Zaoshen Anshen Oral Liquid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zaoshen Anshen Oral Liquid.

Explore the full profile